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Keloid is a fibrotic disease characterized by abnormal accumulation of 
extracellular matrix in the dermis. The keloid matrix contains excess 
collagen and glycosaminoglycans (GAGs), but lacks elastic fiber. 
However, the roles of these matrix components in the pathogenesis of 
keloid are largely unknown. Here, we show that elastin and DANCE (also 
known as fibulin-5), a protein required for elastic fiber formation, are not 
deposited in the extracellular matrix of keloids, due to excess 
accumulation of chondoitin sulfate (CS), although the expression of elastin 
and DANCE is not affected. Amount of CS accumulated in the keloid 
legion was 6.9-fold higher than in normal skin. Fibrillin-1, a scaffold 
protein for elastic fiber assembly, was abnormally distributed in the keloid 
matrix. Addition of purified CS to keloid fibroblast culture resulted in 
abnormal deposition of fibrillin-1, concomitant with significantly 
decreased accumulation of elastin and DANCE in the extracellular matrix. 
We propose that CS plays a crucial role in the development of keloid 
lesions through inhibition of elastic fiber assembly.   
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Keloids are benign dermal tumors that appear as raised, red, itchy, painful 
lesions that develop during the wound-healing process [1]. Keloid lesions 
expand beyond the boundaries of the initial injury site through the rapid 
proliferation of fibroblast-like cells. Keloid lesions contain excess 
amounts of extracellular matrix [2-4]. Collagen types I and VI are the 
major components of the excessive matrix [3, 4], and collagen type III is 
also strongly upregulated in the keloid lesions [4]. 
  Recently, we demonstrated that glycosaminoglycans (GAGs), which are 
an important component of human skin, are abundant in the keloid matrix 
[2]. GAGs can be divided into four classes: (i) chondroitin sulfate (CS) (ii) 
keratan sulfate (KS), (iii) heparan sulfate (HS) / heparin, and (iv) 
hyaluronan (HA).  CS is further divided into five subtypes: CSA, CSB 
(also known as dermatan sulfate, DS), CSC, CSD and CSE. GAGs are 
linear polysaccharides composed of repeating disaccharide units 
consisting of an amino sugar, either N-acetyl-D-glucosamine (D-GlcNAc) 
or N-acetyl-D-galactosamine (D-GalNAc), and an uronic acid, either 
D-glucuronic (D-GlcA) or L-iduronic acid (L-IdoA), with the exception of 
KS. In KS, a galactose residue is present in place of the uronic acid [5]. 
Although the basic sugar backbone is similar among GAGs, subsequent 
modifications including sulfation, deacetylation and epimerization 
distinguish the individual GAG members and are critical for their specific 
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activities [5]. CS, KS and HS, but not HA, are covalently attached to 
protein cores, creating proteoglycans (PGs). Although Swann et al. 
analyzed the differences in PGs between normal skin and scar tissues, 
including keloids, only one sample of normal skin and of keloid tissue was 
examined [6]. Thus, the role of PGs in keloid pathogenesis is largely 
unknown.  
  Elastic fibers are one of the major components of human skin. Elastic 
fibers are lost or markedly reduced in keloid lesions [7, 8], although a 
detailed analysis of elastic fiber components in keloids has not been 
conducted. Elastic fibers are formed from two distinct components: an 
amorphous core of cross-linked elastin and a peripheral mantle of 
microfibrils [9]. In the process of elastic fiber formation, elastin precursors 
(tropoelastin) are deposited onto microfibrils, aligned, and cross-linked to 
form mature elastin [10]. The molecular mechanism of this process 
remains largely unknown. Mice lacking both fibrillin-1 and -2, major 
components of microfibrils, were recently reported to be deficient in 
elastic fiber formation [11], suggesting that microfibrils are required for 
normal assembly of elastin. Fibrillin is thought to act as a scaffold for the 
deposition of tropoelastin onto microfibrils. DANCE (also known as 
fibulin-5) is also required for elastic fiber assembly, as revealed in 
DANCE–deficient mice [12, 13].  
  Here, we analyzed elastic fiber components and glycosaminoglycans in 
keloid lesions, and found that deposition of elastin and DANCE on 
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microfibrils is abrogated and that distribution of fibrillin-1 is abnormal in 
keloid lesions, although these molecules are normally expressed. CS is 
abundant in keloid lesions, and addition of CS to fibroblast culture caused 
inhibition of elastin and DANCE deposition due to aberrant fibrillin 
microfibrils. Thus, CS appears to play an important role in diminished 
elastic fiber formation in keloids. 
 
Materials and Methods 
 
Tissue specimens 
Eighteen patients with keloid (aged 11-75 years) and seven unrelated 
patients (aged 1-69 years) undergoing surgical treatment were enrolled in 
this study (Supplementary Table 1). With approval from Institutional 
Reviewing Board in Kyoto University faculty of medicine in accordance 
with ethical standards as formulated in the Helsinki Declaration, informed 
consent was obtained from all of the patients. Keloid diagnosis was 
performed on the basis of the clinical appearance, history and anatomical 
location. All lesions analyzed in this study satisfied the histological 
criteria for keloids by hematoxylin/eosin (HE) and Elastica van Gieson 
staining. 
  
Histological and immunohistochemical studies 
Tissue samples were fixed in 4% paraformaldehyde at 4°C, and paraffin 
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sections (6 μm) were prepared. Deparaffinized sections were stained with 
HE and Elastica van Gieson. Alcian Blue staining was performed at pH 
2.5, after an incubation with hyaluronidase (Seikagaku Corp., Tokyo, 
Japan) at 60 °C for 2 h, chondroitinase-ABC (Seikagaku Corp.) at 37°C 
for 2 h, or no enzymatic treatment. For immunological staining, 
cryosections (10 μm) were prepared and fixed in 4% paraformaldehyde. 
Sections were incubated with antibodies against human elastin (1:200, 
PR533, EPC, Missouri, USA), human DANCE (1:200, 10A) [14], or 
human fibrillin-1 (1:400, PR217, EPC) for 60 min at room temperature. 
Sections were then incubated with Alexa 488-conjugated anti-mouse IgG 
or Alexa 546-conjugated anti-rabbit IgG (Invitrogen, California, USA). 
Sections were counterstained with Hoechst 33258 for nuclear staining, and 




Tissues were cut into 1~2 mm3 pieces, placed into plastic tissue culture 
dishes, and cultured in Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal calf serum (Invitrogen). Cells were 
propagated at 37°C, and semiconfluent cultures of fibroblasts were 
passaged by trypsinization up to seven times prior to analysis. 
 
Elastic fiber formation by cultured keloid fibroblasts 
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Keloid fibroblasts (1x104 cells) were seeded onto a cover glass and 
cultured in DMEM/F12 (Invitrogen) supplemented with 10% fetal calf 
serum in the presence or absence of CSA, CSB, CSC and HA (400 μg/ml 
each or combinations, Seikagaku Corp.).  After culture for 9 days, 
fibroblast cultures were fixed in 100% methanol at -20°C, and analyzed by 
immunostaining for elastin, DANCE and fibrillin-1. Evaluation of the 
effects of GAGs on elastogenesis was conducted according to previously 
described methods [14, 15, 16] 
 
RT-PCR 
Total RNA was isolated from normal skin and keloid tissue samples using 
the Trizol Reagent (Invitrogen) and RNeasy Mini Kits (Qiagen, Hilden, 
Germany). First-strand cDNA was synthesized from 1 μg total RNA by 
reverse transcription at 42°C for 60 min using the Advantage RT for PCR 
kit (BD Biosciences, California, USA). Specific cDNA fragments were 
amplified using Blend Taq-plus (TOYOBO, Osaka, Japan) with the 
following primers: tropoelastin, AAGCAGCAGCAAAGTTCG and 
ACCTGGGACAACTGGAATCC; fibrillin-1, GTGAGATCAA 
CATCAATGGAGC and TTACACACTCCTGGGAACACTTC; fibulin-1, 
GATGTCCTCCTGGAGGCCTGCTGTG and TTGGGTC 
GGCAGCGGAAGGATCCCAG; DANCE, CGGCACATACTTCTG 
CTCCT and TCAGAATGGGTACTGCGACA; EMILIN-1, ATTA 
TGACCAGAGACAGGC and CCGAGTGCGCCAGCTGCCCC; MAGP-1, 
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ATGAGAGCTGCCTACCTCTTC and CTAGCAGCTC 
CCACAGCTCCT; GAPDH, TGGTATCGTGGAAGGACTCATGAC  and 
ATGCCAGTGAGCTTCCCGTTCAGC. PCR reactions were conducted for 
30 cycles for DANCE, MAGP-1, GAPDH, and 35 cycles for tropoelastin, 
fibrillin-1, fibulin-1 and EMILIN-1, where one PCR cycle consisted of 
denaturation at 94°C for 30 sec, annealing at 58°C for 30 sec, and extension 
at 72°C for 1 min. PCR products were analyzed by agarose gel 
electrophoresis followed by ethidium bromide staining. 
 
High-performance liquid chromatography (HPLC) assays  
Tissues samples were frozen in liquid nitrogen immediately after 
collection and stored at -80°C until analysis. After freeze-drying, samples 
were incubated with 2.5% Actinase E (Kaken Pharmaceutical Corp., Ltd., 
Tokyo, Japan) at 55°C for 24 h. After freeze-thawing, samples were 
centrifuged at 3,000 rpm for 10 min and supernatant were recovered. 
Measurement of CSA/C and CSB was performed according to the method 
of Shinmei et al. [17] with minor modifications. One aliquot of the 
supernatant was treated with 250 mU of Chondroitinase ABC (Seikagaku 
Corp.) and 25 mU of Chondroitinase AC-II (Seikagaku Corp.) in 20 mM 
Tris-HCl buffer (pH 8).  Another aliquot of the supernatant was digested 
by 250 mU of Chondroitinase AC-II in 20mM sodium acetate buffer (pH 
6). In both cases, samples were incubated at 37°C for 2 h and clarified by 
ultrafiltration with a Nanosep filter (molecular size cut-off of 10,000; 
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PALL Corp., New York, USA). The ultrafiltrate was analyzed with 
modifications for the determination of each isomer as follows. The di-4S 
value obtained from the digest of Chondroitinase ACII, which can act on 
CSA/C but not on CSB, was used to determine the diCS-4S levels, and 
the level of diDS-4S was calculated by subtraction of the di-4S value 
obtained from the Chondroitinase ACII digestion from that obtained from 
the Chondroitinase ABC plus Chondroitinase ACII digestion, which 
cleaves both CSA/C and CSB.  The concentration of KS was determined 
according to the method of Shinmei et al. [17] and Yamada et al. [18] with 
minor modifications. Supernatants were treated with 1 mU of Keratanase 
II (Seikagaku Corp.) in 20 mM sodium acetate buffer (pH 6) at 37°C for 3 
h. The samples were then clarified by ultrafiltration, and the filtrate, which 
contains the saturated disaccharides 
ß-galactosyl-(1-4)-6-O-sulfo-N-acetylglucosamine (M-KS) and 
ß-6-O-sulfo-galactosyl-(1-4)-6-O-sulfo-N-acetylglucosamine (D-KS), was 
analyzed by HPLC. The concentration of HA was analyzed according to 
the method of Takazono et al. [19] and Shinmei et al. [17] with minor 
modifications. Supernatant was treated with 2.5 TRU of Streptomyces 
hyalurolyticus hyaluronate lyase (Seikagaku Corp.) in 12.5 mM sodium 
acetate buffer (pH 6) at 37°C for 24 h. Samples were clarified by 





Deposition of elastin and DANCE is strongly reduced and distribution of 
fibrillin-1 is aberrant in keloid tissues 
Keloids are known to lack elastic fibers [7, 8]. However, little is known of 
the detailed mechanisms mediating these changes. We first examined the 
distribution of elastin, fibrillin-1 and DANCE in keloid lesions by 
immunostaining tissue sections. Elastin stained very weakly in keloid 
lesions relative to normal skin (Fig. 1A). Reduced deposition of DANCE, 
a protein required for elastic fiber formation, was also detected in keloid 
tissues (Fig. 1B). The fibrillin-1 distribution was abnormal in keloid 
lesions. Although fibrillin-1 stained as fine fibers in normal skin, this 
protein distributed in thick and irregular bundles in keloid tissue. In 
addtion, we confirmed that elastic fibers are absent in keloid lesions by 
Elastica van Gieson staining (Fig. 1C). These observations suggest that 
the lack of elastic fibers in keloid lesions is due to a deficiency in DANCE 
and elastin depositin in the keloid matrix, and that the abnormal 
distribution of fibrillin-1 may also contribute to the absence of elastic 
fibers in keloid lesions. 
 
Gene expression of proteins required for elastic fibers is normal in keloid 
lesions 
To analyze the mechanisms mediating the strongly reduced levels of 
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elastin and DANCE in keloid lesions, we examined mRNA expression of  
elastin, DANCE, fibrillin-1, fibrillin-2, and other elastic fiber components 
including fibulin-1 [20], EMILIN-1 [21], and MAGP-1 [22] by RT-PCR. 
As shown in Fig. 1D, levels of fibrillin-1, fibrillin-2 and MAGP-1 are 
upregulated in keloids, but mRNA levels of the other components were 
similar to those expressed in normal skin. The high levels of fibrillin-1, 
fibrillin-2, and MAGP-1 expression may play a role in the abnormal 
distribution of fibrillin-1 in keloids (Fig. 1B). These results suggest that 
the lack of elastic fibers in keloids is not due to changes in gene 
expression, but may be due to defective assembly process of the fiber 
components. 
 
Keloid lesions contain high amounts of GAGs, particularly CS  
We reported previously that keloid lesions show metachromasia, 
indicating an excess accumulation of GAGs including CS and HA [2]. 
Among GAG family members, CS is reported to impair elastogenesis in 
vascular smooth muscle cells in several cardiovascular diseases and in 
fibroblasts in congenital diseases [15, 23]. To analyze variations in GAGs 
accumulated in keloid lesions, we first performed Alcian Blue staining 
after digestions with GAG subtype-specific enzymes. In the absence of 
enzymatic treatment, keloid lesions were strongly stained by Alcian Blue, 
whereas normal skin was only weakly stained (Fig. 2A-a, b). After 
digestion by chondroitinase ABC, which selectively reacts with CS, the 
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staining was greatly reduced in keloid samples (Fig. 2A-c). After 
hyaluronidase digestion, the staining in keloid samples also decreased, 
although the effect was less pronounced compared with the chondroitinase 
treatment (Fig. 2A-d). These data suggest that CS and HA accumulate to 
abnormally high levels in keloid lesions. To determine the content of 
GAG family members in keloid lesions, we quantified amounts of CSA/C, 
CSB, HA, and KS using an HPLC system (Table 1). The major GAGs in 
normal skin are HA and CSB (Fig. 2B, C), as reported previously [24]. 
Levels of CS, HA and KS were 6.9-fold, 1.7-fold and 3.0-fold higher, 
respectively, in keloids than in normal skin (Fig. 2B). CSB was the most 
abundant GAG in keloid tissues, and levels of CSA/C and CSB were 
12.1-fold and 5.1-fold increased in keloids relative to normal skin, 
respectively (Fig. 2C). These results indicate that CS is extremely 
abundant GAG in keloid lesions. 
 
CS inhibits elastic fiber formation by cultured keloid fibroblasts 
As CS has been reported to inhibit elastogenesis in several pathological 
conditions [15, 23], we hypothesized that loss of elastic fibers in keloids 
may be caused by excess accumulation of CS. To test this possibility, we 
examined whether addition of purified CS to cultured keloid fibroblasts 
affects elastic fiber formation. In the absence of CS addition, keloid 
fibroblasts developed normal elastic fibers as analyzed by 
immunostaining of DANCE, fibrillin-1 (Fig. 3A), and elastin (Fig. 3B). 
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These three proteins were deposited in a fine meshwork, and DANCE 
colocalized with fibrillin-1. In contrast, addition of purified CS to cultured 
keloid fibroblasts inhibited deposition of these three proteins. Similar 
effects were observed by using normal skin fibroblasts (data not shown). 
In the three subtypes of CS (CSA, CSB and CSC) examined, CSB most 
strongly blocked the deposition of elastic fiber components (Fig. 3A and 
3B). CSA and CSC exhibited no significant difference in the efficiency to 
inhibit the deposition of elastic fiber proteins. The inhibitory effect was 
dose dependent (Supplementary Fig. 1). Treatment of keloid fibroblast 
culture with combination of two CS subtypes increased the inhibition 
efficiency, and the inhibition was most effective when CSB was included 
(Fig. 3A and 3B). The strongest interference was observed by the 
presence of the three subtypes. In contrast, HA had no significant effect 
on the elastic fiber formation (Fig. 3C), and increase concentration of HA 
did not affect elastogenesis (Supplementary Fig.2). These data indicate 
that CS can interfere with elastic fiber formation and that CSB is the most 
effective subtype. The inhibitory effect of CS may be exerted through 
inhibition of fibrillin-1 activity, as fibrillin-1 is reported to act as scaffolds 




In the present study, we found that keloid lesions contain excess amounts 
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of GAGs, particularly CS (6.9-fold higher than normal skin). Moreover, 
CS impaired normal elastic fiber formation when added to keloid 
fibroblast cultures. These results strongly suggest that excess amounts of 
CS may be responsible for the lack of elastic fiber formation in 
developing keloid lesions. This hypothsesis is consistent with previous 
observations that CS interfered with elastic fiber formation in congenital 
diseases, including fetal ductus arterious [23], Costello disease and Hurler 
disease [15], as well as in restenotic lesions after vascular injury [25]. In 
pathogenic cells in these diseases, CS exists as a side chain of versican, 
which is over-expressed in the lesions. Versican is a proteoglycan that is 
present in many types of connective tissues including those in blood 
vessels [26]. Overexpression of an artificial versican that lacks CS side 
chains (known as V3) in neointima after vascular injury leads to increased 
elastic fiber formation in the lesion [27]. These observations further 
support the hypothesis that CS has an inhibitory role in elastogenesis, 
although the molecular mechanism mediating this effect is not clear. We 
previously reported that versican expression was markedly up-regulated in 
keloid lesions [2]. The presence of excess versican is likely to be the 
major source of the CS accumulation in keloid lesions. In the present 
study, we found that CSA/C and CSB were increased 12.1-fold and 
5.1-fold in keloids relative to normal skin, respectively. Since versican has 
CSA/C and CSB side chains, the accumulation of CSA/C and CSB may 
be due to the over-expression of versican.  
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  Elastic fiber formation is a multi-step process controlled by fibrillin-1, 
DANCE and other proteins, although the molecular mechanisms are 
largely unknown. In this process, fibrillin-1 acts as a template on which 
tropoelastin deposits [10]. Fibrillin-1 is crucial for elastic fiber formation 
and mutations in the fibrillin-1 gene cause Marfan syndrome, a hereditary 
connective tissues disease [28]. DANCE is also essential for elastogenesis 
because DANCE deficient mice show human aging-like phenotypes 
caused by disorganized elastic fibers [12, 13]. Recombinant DANCE can 
induce elastic fiber formation, even in serum-free cell culture, suggesting 
that this protein may be an organizer of elastogenesis [14]. DANCE 
deposition on microfibrils is considered to promote coaservation and 
crosslinking of tropoelastin along microfibrils [14]. In the present study, 
we found that both of fibrillin-1 and DANCE deposition is strongly 
reduced in keloid lesions and in the extracellular matrix produced by 
cultured keloid fibroblasts after addition of purified CS. Taken together, 
these observations suggest that CS interferes with developing intact 
fibrillin-1 scaffold, resulted in inhibition of DANCE interactions with 
microfibrils in keloid lesions, finally tropoelastin couldn’t deposit on 
microfibrils (Fig. 3C). In conclusion, our present results strongly suggest 
that excessive accumulation of CS mediate the loss of elastic fibers in 
keloid lesions through inhibition of microfibril template formation. The 
findings described in the present study contribute to a further 
understanding of the pathology of keloids and may lead to new therapies. 
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Interestingly, Costa et al. reported that elastic fibers in keloids were 
recovered concomitantly with an improvement in the clinical appearance 
of the tissue after a pressure treatment [29], suggesting that keloid 
pathogenesis and clinical outcomes correlate well with matrix 
abnormalities. Treatments that reduce the excess CS may induce normal 
elastic fiber formation in the lesions, and could provide a novel therapy in 
the treatment of keloid. As shown in the present study, CSA/C and CSB 
excessively deposite in keloid lesions. Although CSB was the strongest 
inhibitor of elastic fiber formation, and CSA/C also had an inhibitory 
effect against elastogenesis. Thus, therapeutic approaches to reduce all 
three subtypes of CS (CSA, CSB and CSC) are probably required for the 
effective treatment of keloid, and enzyme that digests all CS subtypes 
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Fig. 1. Analysis of elastic fiber components in keloid and normal skin 
tissues. (A, B) Immunostaining of elastic fiber components. Sections 
prepared from the keloid lesions and normal skin were stained with 
antibodies against elastin (A), DANCE and fibrillin-1 (B). Bar=40 μm. 
(C) HE (upper panel) and Elastica Van-Gieson (lower panel) staining of 
the boundary region between keloid and normal skin tissues. k, keloid 
lesion; n, unaffected skin. Bar=500 μm. (D) Analysis of mRNA levels of 
elastic fiber components. The indicated mRNAs from keloid and normal 
skin samples were analyzed by RT-PCR of total RNA.  
 
Fig. 2. Analysis of GAGs accumulation in keloid lesions by Alcian Blue 
staining after enzymatic treatment and HPLC assay. (A) Sections of 
keloid lesions (a) and normal skin (b) were stained with Alcian Blue. 
Sections of keloid lesions were incubated with chondoroitinase ABC (c) 
or hyaruronidase (d) and then stained with Alcian Blue. (B) Analysis of 
CS, HA and KS content in normal skin and keloids by HPLC. Content of 
these GAGs pere mg dry weight of tissue is shown (mean ± SD; n=6). (C) 
Analysis of CSA/C and CSB content in normal skin and keloids. Contents 




Fig. 3. Inhibition of elastic fiber formation by addition of purified CS and 
HA to keloid fibroblast culture. (A, B) Fibroblasts obtained from keloid 
tissues were cultured in the presence or absence of CS. Bar=50 μm. The 
cell culture was then doubly stained with antibodies against DANCE and 
fibrllin-1 (A) or with antibody against elastin (B). Hoechst was used to 
stain nuclei. (C) Fibroblasts obtained from keloid tissues were cultured in 
the presence of HA and stained with antibodies against DANCE and 
fibrllin-1 (top), or with antibody against elastin (bottom). Bar=100 μm. 
(D) A model for insufficient deposition of elastin fiber components in the 
keloid matrix. This model shows that microfibrils are a scaffold for the 
deposition of elastic fiber components. DANCE promotes fibrillar 
deposition and cross-linking of tropoelastins on microfibrils to develop 
elastic fibers in normal skin. In contrast, CS probably prevents formation 
of microfibril platform and thus inhibits recruitment of elastin to 
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Table 1. GAGs in keloid and normal skin tissues quantified by HPLC.
 region sex                  CS HA KS 
CSA/C CSB total
keloid chest F 3.56 5.16 8.72 1.56 0.11
keloid chest M 3.44 4.61 8.05 2.33 0.12
keloid back M 6.14 5.97 12.11 1.55 0.13
keloid chest M 3.31 3.81 7.12 1.87 0.08
keloid ear F 4.21 5.78 9.99 1.29 0.20
keloid neck M 4.11 4.87 8.98 1.12 0.06
normal skin chest M 0.25 0.96 1.21 0.98 0.02
normal skin abdomen F 0.32 0.92 1.24 1.28 0.03
normal skin abcomrn F 0.23 1.36 1.59 1.05 0.00
normal skin abdomen M 0.23 1.05 1.28 0.69 0.01
normal skin back M 0.51 0.92 1.43 0.99 0.12
normal skin back M 0.49 0.71 1.20 0.73 0.05
No. tissue region sex age assays
1 normal skin abdomen F 23 A
2 normal skin abdomen F 22 A
3 normal skin neck M 22 A
4 normal skin abdomen M 69 B
5 normal skin thigh M 57 B
6 normal skin chest M 33 D
7 normal skin abdomen F 14 D
8 normal skin abdomen# M 51 D
9 normal skin abdomen# M 48 D
10 normal skin chest## F 39 D
11 normal skin back# M 75 D
12 keloid sholder F 21 A
13 keloid chest M 37 A
14 keloid sholder M 60 A
15 keloid chest M 27 A
16 keloid chest F 19 B
17 keloid chest M 67 B
18 keloid abdomen M 58 B
19 keloid back F 19 C
20 keloid chest M 31 C
21 keloid chest F 39 D
22 keloid cehst M 11 D
23 keloid back M 37 D
24 keloid chest M 36 D
25 keloid ear F 20 D
26 keloid neck M 48 D
Supplemental Table 1. List of all tissue samples used in this study
#Unaffected skins apart from the leisons obtained from keloid patients.
##Unaffected skin surrounding the keloid lesion. Assays to which the samples were
subjected. A, RT-PCR; B, Alcian blue staining; C, in vitro elastogenesis assay; 
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Supplementary figure legends 
 
Supplementary Fig. 1. A combination of three subtypes of CS inhibits the 
deposition of fibrillin-1, DANCE and elastin in extra cellular matrix by 
cultured keloid fibroblasts in a dose-dependent manner. Keloid fibroblasts 
were cultured in the presence of CSA+CSB+CSC (100, 400, 800 or 1200 
μg/ml ), or the absence of CS as a control. Cultured cells were fixed and 
stained with an antibody against elastin or antibodies against fibrllin-1 and 
DANCE. Counter staining by Hoechst was performed to visualize nuclei. 
Bar =100 μm.  
 
Supplementary Fig. 2. Addition of purified HA has no significant effect 
on elastic fibers formation by cultured keloid fibroblast. Furthermore, HA 
did not affect elastogenasis even though its concentration was increased. 
Keloid fibroblasts were cultured in the presence of 100, 400, 800 or 1200 
μg/ml HA, or the absence of HA. Cultured cells were fixed and doubly 
stained with an antibody against elastin or antibodies against fibrllin-1 and 
DANCE. Counter staining by Hoechst was performed. Bar =100 μm. 
 
